Circulating tumour DNA and resistance mechanisms during EGFR inhibitor therapy in lung cancer

Affiliations

• ¹ Medical Oncology, Clatterbridge Cancer Centre, CH63 4JY, Wirral, UK;; Cancer Research Centre, Department of Molecular and Clinical Cancer Medicine, The University of Liverpool, L3 9TA, Liverpool, UK.
• ² Roy Castle Lung Cancer Research Programme, Institute of Translational Medicine, Department of Molecular and Clinical Cancer Medicine, The University of Liverpool, L7 8TX, Liverpool, UK.